Brief: Acelrx Pharmaceuticals Reports First Quarter 2022 Financial Results And Provides Corporate Update
16/05/2022 13:30
AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* ACELRX PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE
$0.06
Source text for Eikon: ID:nPn88x5qva
Further company coverage: ACRX.O
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial